adplus-dvertising
Connect with us

News

After Medicago shutdown, Canada recovers $40M and research on COVID-19 vaccine

Published

 on

The government of Canada is set to recover about $40 million and research conducted by Medicago into both the COVID-19 vaccine and other pandemic preparedness tools, following the company ceasing operations 10 months ago.

Innovation, Science and Economic Development Minister François-Philippe announced on Friday that Ottawa had reached an agreement with Mitsubishi Chemical Group Corporation (MCG) — Medicago’s parent company — to see a $40-million payment returned to the government, which was owed to the Crown in relation to the construction of the company’s biomanufacturing facility.

The agreement will also see key research and development assets, intellectual property and equipment transferred to Aramis Biotechnologies, a new Canadian company based in Quebec that was formed by former employees of Medicago the same month the latter ceased its operations.

“Our government has always been clear that the technology developed by Medicago is important to our life sciences sector and that we would work with our partners to keep expertise and workers in Quebec,” Champagne said in a statement.

Champagne’s ministry notes in a release that when Medicago ceased operations earlier this year, the government’s goals were to maintain the company’s intellectual property and research assets; ensure a Canadian company retails the technology platform, talent and expertise; and find third-party investors to maintain and expand the company’s platform capabilities in Canada. It writes that the intention is to enhance domestic pandemic preparedness capabilities.

In February, Medicago announced it would shut down its COVID-19 vaccine project after its sole shareholder decided to no longer invest in the company. And with MCG deciding to “proceed with an orderly wind-up of its business operations in Canada and the United States,” Medicago said the group would cease all of the company’s operations.

Medicago made headlines last year when its Covifenz shot was the first Canadian-developed COVID-19 vaccine was approved for use by Health Canada. It was the world’s first-ever plant-based jab authorized for human use, and first Canadian vaccine of any kind to be approved in more than 20 years.

But a month after its approval, the World Health Organization rejected the vaccine because of the company’s ties to tobacco giant Philip Morris, which owned a one-third stake in Medicago. Those ties were cut in December 2022.

MCG said once the vaccine was licensed in Canada, it began preparations for a transition to “commercial production,” but 10 months ago said it was terminating its operations due to the current global demand for the COVID-19 vaccine. It added “economic context” for the vaccine and Medicago’s challenges in transferring to commercial production as its reasoning.

More on Health

In 2020, Medicago received $173 million from the federal government for facility construction, and research and development of the vaccine. When the announcement about ceasing operations was made, Champagne’s spokesperson Laurie Bouchard said in a statement to Global News that Ottawa was disappointed in the decision by MCG, a sentiment echoed by then-health minister Jean-Yves Duclos.

With Friday’s announcement, Duclos, now minister of public services and procurement, said this decision was “great news.”

“This demonstrates our commitment to continuing to grow the Canadian life sciences sector to improve health care for Canadians and Quebecers, increase our resilience to face future health emergencies, and create good jobs for the middle class, including here in Quebec City,” Duclos said in a statement.

with files from Global News’ Sean Boynton

 

728x90x4

Source link

Continue Reading

News

RCMP investigating after three found dead in Lloydminster, Sask.

Published

 on

LLOYDMINSTER, SASK. – RCMP are investigating the deaths of three people in Lloydminster, Sask.

They said in a news release Thursday that there is no risk to the public.

On Wednesday evening, they said there was a heavy police presence around 50th Street and 47th Avenue as officers investigated an “unfolding incident.”

Mounties have not said how the people died, their ages or their genders.

Multiple media reports from the scene show yellow police tape blocking off a home, as well as an adjacent road and alleyway.

The city of Lloydminster straddles the Alberta-Saskatchewan border.

Mounties said the three people were found on the Saskatchewan side of the city, but that the Alberta RCMP are investigating.

This report by The Canadian Press was first published on Sept. 12, 2024.

Note to readers: This is a corrected story; An earlier version said the three deceased were found on the Alberta side of Lloydminster.

The Canadian Press. All rights reserved.



Source link

Continue Reading

News

Three injured in Kingston, Ont., assault, police negotiating suspect’s surrender

Published

 on

KINGSTON, Ont. – Police in Kingston, Ont., say three people have been sent to hospital with life-threatening injuries after a violent daytime assault.

Kingston police say officers have surrounded a suspect and were trying to negotiate his surrender as of 1 p.m.

Spokesperson Const. Anthony Colangeli says police received reports that the suspect may have been wielding an edged or blunt weapon, possibly both.

Colangeli says officers were called to the Integrated Care Hub around 10:40 a.m. after a report of a serious assault.

He says the three victims were all assaulted “in the vicinity,” of the drop-in health centre, not inside.

Police have closed Montreal Street between Railway Street and Hickson Avenue.

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.



Source link

Continue Reading

News

Government intervention in Air Canada talks a threat to competition: Transat CEO

Published

 on

Demands for government intervention in Air Canada labour talks could negatively affect airline competition in Canada, the CEO of travel company Transat AT Inc. said.

“The extension of such an extraordinary intervention to Air Canada would be an undeniable competitive advantage to the detriment of other Canadian airlines,” Annick Guérard told analysts on an earnings conference call on Thursday.

“The time and urgency is now. It is time to restore healthy competition in Canada,” she added.

Air Canada has asked the federal government to be ready to intervene and request arbitration as early as this weekend to avoid disruptions.

Comments on the potential Air Canada pilot strike or lock out came as Transat reported third-quarter financial results.

Guérard recalled Transat’s labour negotiations with its flight attendants earlier this year, which the company said it handled without asking for government intervention.

The airline’s 2,100 flight attendants voted 99 per cent in favour of a strike mandate and twice rejected tentative deals before approving a new collective agreement in late February.

As the collective agreement for Air Transat pilots ends in June next year, Guérard anticipates similar pressure to increase overall wages as seen in Air Canada’s negotiations, but reckons it will come out “as a win, win, win deal.”

“The pilots are preparing on their side, we are preparing on our side and we’re confident that we’re going to come up with a reasonable deal,” she told analysts when asked about the upcoming negotiations.

The parent company of Air Transat reported it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31. The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

It attributed reduced revenues to lower airline unit revenues, competition, industry-wide overcapacity and economic uncertainty.

Air Transat is also among the airlines facing challenges related to the recall of Pratt & Whitney turbofan jet engines for inspection and repair.

The recall has so far grounded six aircraft, Guérard said on the call.

“We have agreed to financial compensation for grounded aircraft during the 2023-2024 period,” she said. “Alongside this financial compensation, Pratt & Whitney will provide us with two additional spare engines, which we intend to monetize through a sell and lease back transaction.”

Looking ahead, the CEO said she expects consumer demand to remain somewhat uncertain amid high interest rates.

“We are currently seeing ongoing pricing pressure extending into the winter season,” she added. Air Transat is not planning on adding additional aircraft next year but anticipates stability.

“(2025) for us will be much more stable than 2024 in terms of fleet movements and operation, and this will definitely have a positive effect on cost and customer satisfaction as well,” the CEO told analysts.

“We are more and more moving away from all the disruption that we had to go through early in 2024,” she added.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.



Source link

Continue Reading

Trending